BioTrove targets $75M in IPO filing
Source: Bizjournals.com (Original Article)
BioTrove Inc., a maker of life sciences research products, has filed for a $75 million initial public offering, according to documents filed with the U.S. Securities and Exchange Commission.
Woburn-based BioTrove offers two technology platforms, including the RapidFire systems and its OpenArray tools used in genomic research for science-related industries.
BioTrove generated $4.8 million in revenue last year and posted a net loss of nearly $16 million, according to the SEC filing.
Last November, BioTrove named Jeffrey Leathe as the company's new CFO. Leathe had previously served as CFO and executive vice president of Apogent Technologies Inc., a Portsmouth, N.H.-based provider of laboratory and life sciences research Instant Approval Credit Cards products that was sold in 2004 to Fisher Scientific Inc.